This week, there’s no guarantee that an updated version of the Senate drug pricing bill will be filed, and the Congressional Budget Office is not expected to finish estimating the impact of the House drug pricing bill, which also could include some changes. After Senate Finance Committee Chair Chuck Grassley (R-IA) told Inside Health Policy that he planned to file an updated version of drug pricing legislation this week, his office said there is no timeline, and a senior...